NASD · Healthcare · Medical Devices · USA
SI-BONE Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.
SI-BONE manufactures titanium implants and associated instruments for treating spinal and pelvic conditions, including sacroiliac joint problems, spine fusion procedures, and pelvic trauma. The company sells its products through a direct sales force in the United States and via direct sales, agents and resellers in other countries.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the SI-BONE Inc stock.
Overvalued: intrinsic value $7.96 per share, market price $20.54, margin of safety -158.2% (as of 2026-10-20).
A 1.6x revenue multiple, discounted for its losses, values the shares at $7.96; the price of $20.54 is 158% above that value.
Leak Score: 46/100 on 9 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
42 more in this industry show a wider margin of safety.
SIBN is overvalued (as of the 2026-10-20 close). A 1.6x revenue multiple, discounted for its losses, values the shares at $7.96; the price of $20.54 is 158% above that value.
$7.96 per share (as of the 2026-10-20 close), against a market price of $20.54. That is a margin of safety of -158.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
46 out of 100, which we rate "On Watch", on 9 of 12 value investing signals.